NANODIAGNOSTIC TECHNOLOGY, LLC

Medtech · Private

Integrated nanosensor-smartphone platform for rapid detection of organophosphate pesticide exposure biomarkers from finger-stick blood samples

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Total capital
$2.2M
Grants
$2.2M
6 awards
6.0× sector median 1 award
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median 2 patents

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history, newest first
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Development of an integrated smartphone-nanosensor platform for onsite biomonitoring of exposure to pesticides$695,405
Federal grantDepartment of Health and Human Services · Phase II · Development of an integrated smartphone-nanosensor platform for onsite biomonitoring of exposure to pesticides$204,188
Federal grantDepartment of Health and Human Services · Phase II · Development of an integrated smartphone-nanosensor platform for onsite biomonitoring of exposure to pesticides$915,031
Federal grantDepartment of Health and Human Services · Phase I · NanoDiagnotic Technology I-Corps Training$55,000
Federal grantDepartment of Health and Human Services · Phase I · Development of an integrated smartphone/resistive nanosensor for onsite biomonitoring of exposure to pesticides$255,880
Federal grantDepartment of Agriculture · Paper/nanotechnology-based Bioanalytical System For Rapid Detection Of Pesticides In Food And Water$99,999
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2290EDEN MEDICAL, INC.——
2291INTUITAP MEDICAL, INC.——
2292SINGLETO2 THERAPEUTICS LLC——
2293NANODIAGNOSTIC TECHNOLOGY, LLC——
2294POPNEURON LLC——
2295Paxos Medical Inc.—$2.1M
2296COBIO DIAGNOSTICS INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

No people are linked to this company yet.

People appear here when they are named as related persons in the company's own Form D filings. We don't infer people from social profiles.

Checked: SEC EDGAR Form D related persons through

Patents

No patents are on record under this company's name.

USPTO publishes applications about 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won't match.

Checked: USPTO granted patents and published applications

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.